REMOTE CLINICAL ASSESSMENT

Using the most advanced modes of telehealth delivery, NeuroMerit has found a distinct advantage in lending this growing technological advancement to assessment in clinical trials. At NeuroMerit, we offer remote clinical assessments for exams including NIH Stroke Scale (NIHSS), Montreal Cognitive Assessment (MoCA), Modified Rankin Score (mRS) and more. All assessments are provided remotely in partnership with Teladoc Health by experts in the field of vascular and interventional neurology.

NEUROMERIT CAN SERVE AS THE CLINICAL CORE LAB FOR YOUR NEXT CLINICAL TRIAL

Remote assessments are advantageous in that they provide reliable contact with patients remotely in any location thereby reducing the rate of loss to follow-up. Additionally, in a blinded fashion, these exams reduce interrater site variability by providing a panel of vascular & interventional neurological experts performing all study assessments with uniformity. Remote patient assessment in clinical trials is the next level of advancement in clinical research offered by the NeuroMerit Clinical Core Lab.

REMOTE CLINICAL ASSESSMENT

Using the most advanced modes of telehealth delivery, NeuroMerit has found a distinct advantage in lending this growing technological advancement to assessment in clinical trials. At NeuroMerit, we offer remote clinical assessments for exams including NIH Stroke Scale (NIHSS), Montreal Cognitive Assessment (MoCA), Modified Rankin Score (mRS) and more. All assessments are provided remotely in partnership with Teladoc Health by experts in the field of vascular and interventional neurology.

NEUROMERIT CAN SERVE AS THE CLINICAL CORE LAB FOR YOUR NEXT CLINICAL TRIAL

Remote assessments are advantageous in that they provide reliable contact with patients remotely in any location thereby reducing the rate of loss to follow-up. Additionally, in a blinded fashion, these exams reduce interrater site variability by providing a panel of vascular & interventional neurological experts performing all study assessments with uniformity. Remote patient assessment in clinical trials is the next level of advancement in clinical research offered by the NeuroMerit Clinical Core Lab.

FDA NEWS RELEASE

FDA Takes Additional Steps to

Advance Decentralized Clinical Trials

Remote Clinical Assessment Publications

NIHSS & Neurologic Exam

MoCA

mRS

CONSULTANTS

MAY NOUR, MD, PHD
INTERVENTIONAL NEUROLOGIST

Dr. Nour is a dually trained vascular and interventional neurologist, completing her training at the University of California, Los Angeles (UCLA). She earned her medical degree (MD) from the University of Arizona College of Medicine and her doctorate degree (PhD) in neurosciences from the University of Oklahoma Center for Neurosciences. As medical director of California’s first mobile stroke unit which began clinical operations in 2017, Dr. Nour has extensive, first hand experience in initiation of mobile stroke programs and concrete knowledge of rig build and design, hardware/software integration, models for effective clinical staffing, clinical operating procedures, integration into EMS systems of care, budget/cost analysis and QI/QA for these specialized ambulance programs which bring the hospital to the patient. As a PI, Co-PI and Investigator for multiple clinical trials in the fields of vascular neurology and neurointervention, Dr. Nour has extensive experience in telehealth applications, clinical trial design, assessment and outcome analysis. Dr. Nour is currently an assistant professor of neurology and radiology at the University of California, Los Angeles.

Viktor Szeder, MD, PhD
INTERVENTIONAL NEUROLOGIST

Dr. Szeder is subspecialty trained in NeuroInterventional/NeuroEndovascular surgery (UCLA), Vascular/Stroke Neurology and NeuroCritical Care (Columbia University). He earned his MD and PhD in Neurosciences at Charles University, Prague and MSc in patient oriented research/biostatistics at Columbia University, New York. He serves as clinical staff physician of the UCLA NeuroInterventional/NeuroEndovascular service as well as vascular neurologist of California’s first Mobile Stroke Unit, Arline & Henry Gluck Mobile Stroke Rescue Program.
His research focus is on clinical outcomes and treatment modalities in patients with acute stroke, brain aneurysm and vascular malformations. He has authored or co-authored over 45 peer-reviewed articles, 13 book chapters and over 102 scientific abstracts. He has also presented at over 40 local, national and international meetings and symposia and participated in over 35 clinical studies and trials. He serves on multiple local/national and international committees involved in quality control initiatives and assessments as well as campaigns of expanding mechanical thrombectomy access. Dr. Szeder is an Associate Clinical Professor at UCLA, David Geffen School of Medicine.

Jeffrey L Saver, MD
VASCULAR NEUROLOGIST

Dr. Saver is SA Vice-Chair and Professor of Neurology at UCLA, and Director of the UCLA Comprehensive Stroke and Vascular Neurology Program. He trained at Harvard Medical School, the Harvard-Longwood Neurology Training Program (neurology), the University of Iowa (neurobehavior), and Brown (vascular neurology). Author of over 670 research articles, 2 books, and 40 book chapters, Dr. Saver’s research interests are in acute stroke treatment, stroke prevention, neuroimaging, clinical trial design, and neurocognitive consequences of stroke. He served as PI of the NIH-NINDS FAST-MAG trial, Global Co-PI of the SWIFT PRIME trial, and Chair of the American Heart Association Stroke Council. He is currently Associate Editor at JAMA, the Journal of the American Medical Association, and Editorial Board Member at the journal Circulation. Dr. Saver is a recipient of the Feinberg Award from the American Stroke Association, the Distinguished Scientist Award from the American Heart Association, and the Lifetime Research Award from the World Stroke Organization.

CONSULTANTS

May Nour, MD, PhD

May Nour, MD, PhD

Interventional Neurologist

SEE BIO

Jeffrey Saver, MD

Jeffrey Saver, MD

Vascular Neurologist

SEE BIO

Viktor Szeder, MD, PHD

Viktor Szeder, MD, PHD

Interventional Neurologist

SEE BIO

May Nour, MD, PhD

Dr. Nour is a dually trained vascular and interventional neurologist, completing her training at the University of California, Los Angeles (UCLA). She earned her medical degree (MD) from the University of Arizona College of Medicine and her doctorate degree (PhD) in neurosciences from the University of Oklahoma Center for Neurosciences. As medical director of California’s first mobile stroke unit which began clinical operations in 2017, Dr. Nour has extensive, first hand experience in initiation of mobile stroke programs and concrete knowledge of rig build and design, hardware/software integration, models for effective clinical staffing, clinical operating procedures, integration into EMS systems of care, budget/cost analysis and QI/QA for these specialized ambulance programs which bring the hospital to the patient. As a PI, Co-PI and Investigator for multiple clinical trials in the fields of vascular neurology and neurointervention, Dr. Nour has extensive experience in telehealth applications, clinical trial design, assessment and outcome analysis. Dr. Nour is currently an assistant professor of neurology and radiology at the University of California, Los Angeles.

Jeffrey Saver, MD

Dr. Saver is SA Vice-Chair and Professor of Neurology at UCLA, and Director of the UCLA Comprehensive Stroke and Vascular Neurology Program. He trained at Harvard Medical School, the Harvard-Longwood Neurology Training Program (neurology), the University of Iowa (neurobehavior), and Brown (vascular neurology). Author of over 670 research articles, 2 books, and 40 book chapters, Dr. Saver’s research interests are in acute stroke treatment, stroke prevention, neuroimaging, clinical trial design, and neurocognitive consequences of stroke. He served as PI of the NIH-NINDS FAST-MAG trial, Global Co-PI of the SWIFT PRIME trial, and Chair of the American Heart Association Stroke Council. He is currently Associate Editor at JAMA, the Journal of the American Medical Association, and Editorial Board Member at the journal Circulation. Dr. Saver is a recipient of the Feinberg Award from the American Stroke Association, the Distinguished Scientist Award from the American Heart Association, and the Lifetime Research Award from the World Stroke Organization.

Viktor Szeder, MD, PhD, MSc

Dr. Szeder is subspecialty trained in NeuroInterventional/NeuroEndovascular surgery (UCLA), Vascular/Stroke Neurology and NeuroCritical Care (Columbia University). He earned his MD and PhD in Neurosciences at Charles University, Prague and MSc in patient oriented research/biostatistics at Columbia University, New York. He serves as clinical staff physician of the UCLA NeuroInterventional/NeuroEndovascular service as well as vascular neurologist of California’s first Mobile Stroke Unit, Arline & Henry Gluck Mobile Stroke Rescue Program. His research focus is on clinical outcomes and treatment modalities in patients with acute stroke, brain aneurysm and vascular malformations. He has authored or co-authored over 45 peer-reviewed articles, 13 book chapters and over 102 scientific abstracts. He has also presented at over 40 local, national and international meetings and symposia and participated in over 35 clinical studies and trials. He serves on multiple local/national and international committees involved in quality control initiatives and assessments as well as campaigns of expanding mechanical thrombectomy access. Dr. Szeder is an Associate Clinical Professor at UCLA, David Geffen School of Medicine.

Twitter feed is not available at the moment.

Contact NeuroMerit

Use the form below to contact the NeuroMerit Company, schedule a consultation or request general information about our services.

Phone

(424) 259-1233

Email

info@neuromerit.com

HEADQUARTERS

Los Angeles, CA